Found: 48
Select item for more details and to access through your institution.
Evaluation of the effect of obesity on voriconazole serum concentrations.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 12, p. 2957, doi. 10.1093/jac/dks312
- By:
- Publication type:
- Article
Role of Isavuconazonium Sulphate for the Treatment of Blastomycosis: A Case Series and Antifungal Susceptibility.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection among Kidney Transplant Recipients: A Large Single-Center Experience.
- Published in:
- Critical Care Research & Practice, 2024, v. 2024, p. 1, doi. 10.1155/2024/7140548
- By:
- Publication type:
- Article
Prophylaxis of Invasive Fungal Infections: A Review of the Use of Posaconazole.
- Published in:
- Clinical Medicine: Therapeutics, 2009, n. 1, p. 1399, doi. 10.4137/CMT.S1948
- By:
- Publication type:
- Article
Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 8, p. 796, doi. 10.1177/10600280231207899
- By:
- Publication type:
- Article
Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 597, doi. 10.1177/10600280221118959
- By:
- Publication type:
- Article
Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Infection in Renal Transplant Recipients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Demonstration of Resistant or Wild-Type Virus in Recurrent Viremia After Ganciclovir-Resistant Cytomegaloviral Infection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal Dysfunction.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pre‐transplant bariatric surgery is not associated with an increased risk of infection after kidney transplant.
- Published in:
- Transplant International, 2021, v. 34, n. 10, p. 1989, doi. 10.1111/tri.13958
- By:
- Publication type:
- Article
Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy.
- Published in:
- Drugs, 2009, v. 69, n. 11, p. 1403, doi. 10.2165/00003495-200969110-00002
- By:
- Publication type:
- Article
Impact of High‐Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 7, p. 694, doi. 10.1002/phar.2126
- By:
- Publication type:
- Article
Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 10, p. 1258, doi. 10.1002/phar.1987
- By:
- Publication type:
- Article
Fosfomycin for the Treatment of Cystitis in the Abdominal Solid Organ Transplant Population.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 5, p. 599, doi. 10.1002/phar.1924
- By:
- Publication type:
- Article
Pulmonary fungal infections.
- Published in:
- Respirology, 2012, v. 17, n. 6, p. 913, doi. 10.1111/j.1440-1843.2012.02150.x
- By:
- Publication type:
- Article
Fungal Infections in Liver Transplant Recipients.
- Published in:
- Journal of Fungi, 2021, v. 7, n. 7, p. 1, doi. 10.3390/jof7070524
- By:
- Publication type:
- Article
Infective endocarditis is rare in patients with hematologic malignancy and neutropenia.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 3, p. 1, doi. 10.1111/tid.14302
- By:
- Publication type:
- Article
Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre‐exposure prophylaxis of COVID‐19: A case series.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 6, p. 1, doi. 10.1111/tid.13932
- By:
- Publication type:
- Article
Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 5, p. 1, doi. 10.1111/tid.13864
- By:
- Publication type:
- Article
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 4, p. 1, doi. 10.1111/tid.13898
- By:
- Publication type:
- Article
Belatacept may result in profound and persistent loss of cytomegalovirus‐specific cell‐mediated immunity: A case report.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 2, p. 1, doi. 10.1111/tid.13795
- By:
- Publication type:
- Article
Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus‐specific cell mediated immunity.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 1, p. 1, doi. 10.1111/tid.13766
- By:
- Publication type:
- Article
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13693
- By:
- Publication type:
- Article
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13687
- By:
- Publication type:
- Article
Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantation.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13617
- By:
- Publication type:
- Article
Successful management of T‐cell mediated rejection in a recent kidney transplant recipient with COVID‐19 associated severe acute respiratory syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Cytomegalovirus antiviral stewardship in the COVID‐19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13586
- By:
- Publication type:
- Article
Impact and outcomes of primary cytomegalovirus disease in seronegative abdominal solid organ transplant recipients of cytomegalovirus unexposed donors (D‐/R‐).
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 3, p. 1, doi. 10.1111/tid.13564
- By:
- Publication type:
- Article
Organ recovery from deceased donors with prior COVID‐19: A case series.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 2, p. 1, doi. 10.1111/tid.13503
- By:
- Publication type:
- Article
Pre‐transplant bariatric surgery is associated with increased fungal infection after liver transplant.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 2, p. 1, doi. 10.1111/tid.13484
- By:
- Publication type:
- Article
Epidemiology, management, and graft outcomes after West Nile virus encephalitis in kidney transplant recipients.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 4, p. 1, doi. 10.1111/tid.13317
- By:
- Publication type:
- Article
Prediction of cytomegalovirus infection: A single‐center experience utilizing a newly available cell‐mediated immunity assay by flow cytometry, a risk factor screening tool, and serologically demonstrated immunity.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 4, p. 1, doi. 10.1111/tid.13311
- By:
- Publication type:
- Article
A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 5, p. N.PAG, doi. 10.1111/tid.13156
- By:
- Publication type:
- Article
Evaluation of infectious risk and outcomes in the hmong renal transplant population.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 5, p. N.PAG, doi. 10.1111/tid.13142
- By:
- Publication type:
- Article
Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 3, p. N.PAG, doi. 10.1111/tid.13080
- By:
- Publication type:
- Article
Comparison of risk factors and outcomes of daptomycin‐susceptible and ‐nonsusceptible vancomycin‐resistant enterococcus faecium infections in liver transplant recipients; A reply to Lewis et al.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance.
- Published in:
- Clinical Transplantation, 2024, v. 38, n. 9, p. 1, doi. 10.1111/ctr.15453
- By:
- Publication type:
- Article
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern era.
- Published in:
- Clinical Transplantation, 2024, v. 38, n. 1, p. 1, doi. 10.1111/ctr.15217
- By:
- Publication type:
- Article
Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 12, p. 1, doi. 10.1111/ctr.15142
- By:
- Publication type:
- Article
Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomes.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 6, p. 1, doi. 10.1111/ctr.14979
- By:
- Publication type:
- Article
Seasonal variation of cytomegalovirus disease in kidney transplant recipients.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 1, p. 1, doi. 10.1111/ctr.14852
- By:
- Publication type:
- Article
A pilot study of an intensified ganciclovir dosing strategy for treatment of cytomegalovirus disease in kidney and/or pancreas transplant recipients.
- Published in:
- Clinical Transplantation, 2021, v. 35, n. 10, p. 1, doi. 10.1111/ctr.14427
- By:
- Publication type:
- Article
Valganciclovir prophylaxis extension from 3 to 6 months in high‐risk pancreas‐transplant recipients does not impact incidence of cytomegalovirus infection at 12 months.
- Published in:
- Clinical Transplantation, 2021, v. 35, n. 8, p. 1, doi. 10.1111/ctr.14379
- By:
- Publication type:
- Article
Bimonthly viral monitoring for late‐onset cytomegalovirus infection—Balancing efficacy with patient palatability; A reply to Melgarejo et al.
- Published in:
- Clinical Transplantation, 2021, v. 35, n. 8, p. 1, doi. 10.1111/ctr.14348
- By:
- Publication type:
- Article
The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients.
- Published in:
- Clinical Transplantation, 2019, v. 33, n. 8, p. N.PAG, doi. 10.1111/ctr.13636
- By:
- Publication type:
- Article
The feared five fungal infections in kidney transplant recipients: A single‐center 20‐year experience.
- Published in:
- Clinical Transplantation, 2018, v. 32, n. 7, p. 1, doi. 10.1111/ctr.13289
- By:
- Publication type:
- Article